Patel Kinnari
SEC insider (Form 3/4/5 filer). CIK 0001725929. Officer at ROCKET PHARMACEUTICALS, INC. (RCKT). 6 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2025. Located in CRANBURY, NJ.
Companies Patel Kinnari has filed insider reports for
- ROCKET PHARMACEUTICALS, INC. (RCKT): Officer, See Remarks
Patel Kinnari
CIK: 0001725929
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ROCKET PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 20, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SaleDirect767 shares at avg. $6.45$5K - May 16, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SaleDirect1.4K shares at avg. $6.53$9K - Apr 9, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
PurchaseIndirect21.1K shares at avg. $4.70$99K - Feb 21, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SaleDirect6.1K shares at avg. $10.58$64K - Feb 11, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect57.8K shares- - Nov 21, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
SaleDirect4.6K shares at avg. $13.05$60K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale | 767 | $6.45 | $4,944 | Direct |
| May 16, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale | 1,409 | $6.53 | $9,198 | Direct |
| Apr 9, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Purchase | 21,099 | $4.70 | $99,165 | Indirect |
| Feb 21, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale | 6,078 | $10.58 | $64,305 | Direct |
| Feb 11, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award | 57,786 | - | - | Direct |
| Nov 21, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale | 4,588 | $13.05 | $59,892 | Direct |
1-6 of 6 transactions